200 related articles for article (PubMed ID: 26130791)
1. Polymorphisms of MMP9 and TIMP2 in Patients with Varicose Veins.
Kunt AT; Isbir S; Gormus U; Kahraman OT; Arsan S; Yilmaz SG; Isbir T
In Vivo; 2015; 29(4):461-5. PubMed ID: 26130791
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins.
Kurzawski M; Modrzejewski A; Pawlik A; Droździk M
Clin Exp Dermatol; 2009 Jul; 34(5):613-7. PubMed ID: 19508478
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of TIMP2-418G/C and MMP9-1562C/T variants on the male infertility risk.
Roshankhah S; Mansouri K; Bakhtiari M; Salahshoor MR; Asgari R
Mol Biol Rep; 2019 Feb; 46(1):861-866. PubMed ID: 30515695
[TBL] [Abstract][Full Text] [Related]
4. Investigation of association between genetic polymorphisms of MMP2, MMP8, MMP9 and TIMP2 and development of varicose veins in the Slovak Population - pilot study.
Mazuchová J; Halašová E; Mazuch J; Šarlinová M; Valentová V; Franeková M; Zelník Š; Krkošková K; Javorka K; Péč M; Grendár M
Physiol Res; 2020 Dec; 69(Suppl 3):S443-S454. PubMed ID: 33471544
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins.
Xu HM; Zhao Y; Zhang XM; Zhu T; Fu WG
J Surg Res; 2011 Jun; 168(1):e143-8. PubMed ID: 21195432
[TBL] [Abstract][Full Text] [Related]
6. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas.
Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N
J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564
[TBL] [Abstract][Full Text] [Related]
7. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
8. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
[TBL] [Abstract][Full Text] [Related]
9. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
O-Charoenrat P; Khantapura P
Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
[TBL] [Abstract][Full Text] [Related]
10. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.
Srivastava P; Lone TA; Kapoor R; Mittal RD
Arch Med Res; 2012 Feb; 43(2):117-24. PubMed ID: 22374248
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
12. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
Sharma KL; Misra S; Kumar A; Mittal B
Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
[TBL] [Abstract][Full Text] [Related]
13. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer.
Park KS; Kim SJ; Kim KH; Kim JC
J Gastroenterol Hepatol; 2011 Feb; 26(2):391-7. PubMed ID: 21261731
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease.
Park KS; Min Y; Park SR; Kim EH; Lee DJ; Bang D; Lee ES
Tissue Antigens; 2012 May; 79(5):333-9. PubMed ID: 22428754
[TBL] [Abstract][Full Text] [Related]
16. Gene polymorphism -418 G/C of tissue inhibitor of metalloproteinases 2 is associated with abdominal aortic aneurysm.
Mikołajczyk-Stecyna J; Korcz A; Gabriel M; Pawlaczyk K; Oszkinis G; Słomski R
J Vasc Surg; 2015 May; 61(5):1114-9. PubMed ID: 24534323
[TBL] [Abstract][Full Text] [Related]
17. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
[TBL] [Abstract][Full Text] [Related]
19. Association of APOE, GCPII and MMP9 polymorphisms with common diseases and lipid levels in an older adult/elderly cohort.
Mazzotti DR; Singulane CC; Ota VK; Rodrigues TP; Furuya TK; de Souza FJ; Cordeiro BG; de Oliveira Amaral CM; Chen ES; Jacomini A; de Arruda Cardoso Smith M; Borsatto-Galera B
Gene; 2014 Feb; 535(2):370-5. PubMed ID: 24291031
[TBL] [Abstract][Full Text] [Related]
20. Association of MMP-9 gene polymorphisms with Behçet's disease risk.
Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
